共 50 条
- [43] Barriers to Receipt of Prenatal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Among Mothers of Infants Aged <4 Months with Pertussis - California, 2016 [J]. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2018, 67 (38): : 1068 - 1071
- [44] EFFECT OF PRIMING WITH DIPHTHERIA AND TETANUS TOXOIDS COMBINED WITH WHOLE-CELL PERTUSSIS-VACCINE OR WITH ACELLULAR PERTUSSIS-VACCINE ON THE SAFETY AND IMMUNOGENICITY OF A BOOSTER DOSE OF AN ACELLULAR PERTUSSIS-VACCINE CONTAINING A GENETICALLY INACTIVATED PERTUSSIS TOXIN IN 15-MONTH-OLD TO 21-MONTH-OLD CHILDREN [J]. JOURNAL OF PEDIATRICS, 1995, 127 (02): : 238 - 243
- [47] COMPARISON OF A 3-COMPONENT ACELLULAR PERTUSSIS-VACCINE WITH A WHOLE-CELL PERTUSSIS-VACCINE IN 4-YEAR-OLD THROUGH 6-YEAR-OLD CHILDREN [J]. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 1994, 148 (05): : 503 - 507
- [50] Safety and immunogenicity of two inactivated poliovirus vaccines in combination with an acellular pertussis vaccine and diphtheria and tetanus toxoids in seventeen- to nineteen-month-old infants [J]. JOURNAL OF PEDIATRICS, 1997, 130 (04): : 525 - 531